AstraZeneca’s Imfinzi Gets Expanded EU Label With Approval for Gastric Cancer – WSJ
AstraZeneca received European Union approval for its Imfinzi drug to treat early-stage gastric and gastroesophageal cancers. View more. AstraZeneca …Read More
The Heartbeat of World events
AstraZeneca received European Union approval for its Imfinzi drug to treat early-stage gastric and gastroesophageal cancers. View more. AstraZeneca …Read More